New shot could shield babies from dangerous RSV
NCT ID NCT05110261
First seen Apr 10, 2026 · Last updated May 22, 2026 · Updated 10 times
Summary
This study tested a single dose of nirsevimab, an antibody, to prevent severe RSV lung infections in healthy infants born at 29 weeks or later. About 800 babies in China received either the antibody or a placebo and were monitored for 150 days. The goal was to see if nirsevimab safely reduces doctor visits and hospital stays caused by RSV.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOWER RESPIRATORY TRACT INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Beijing, 100191, China
-
Research Site
Changde, 415000, China
-
Research Site
Changsha, 410005, China
-
Research Site
Changsha, 410008, China
-
Research Site
Chengdu, 610000, China
-
Research Site
Chengdu, 610041, China
-
Research Site
Guangzhou, 510120, China
-
Research Site
Guangzhou, 510150, China
-
Research Site
Guangzhou, 510280, China
-
Research Site
Hangzhou, 310006, China
-
Research Site
Hangzhou, 310013, China
-
Research Site
Jiaxing, 314000, China
-
Research Site
Kunming, 650101, China
-
Research Site
Langfang, 065000, China
-
Research Site
Linfen, 041099, China
-
Research Site
Linfen, 41081, China
-
Research Site
Nanjing, 210009, China
-
Research Site
Ningbo, 315012, China
-
Research Site
Sanmenxia, 472000, China
-
Research Site
Sanya, 572000, China
-
Research Site
Shantou, 515041, China
-
Research Site
Shaoxing, 311800, China
-
Research Site
Shenzhen, 518106, China
-
Research Site
Suzhou, 215002, China
-
Research Site
Tangshan, 63003, China
-
Research Site
Tianjin, 300201, China
-
Research Site
Wenzhou, 325027, China
-
Research Site
Xinxiang, 453000, China
-
Research Site
Zhengzhou, 450018, China
-
Research Site
Zhongshan, 528400, China
Conditions
Explore the condition pages connected to this study.